Medroxyprogesterone Acetate is used for: Menorrhagia; endometriosis; secondary amenorrhoea; contraception; abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology.
Recorded in the NepalDoc medicine catalog for Medroxyprogesterone Acetate.
Medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy.
From the U.S. FDA-approved label for Medroxyprogesterone Acetate. Full label: DailyMed.
Medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy.
From the U.S. FDA-approved label for Medroxyprogesterone Acetate. Full label: DailyMed.
The recommended dose is 150 mg of medroxyprogesterone acetate injectable suspension every 3 months (13 weeks) administered by deep, intramuscular (IM) injection in the gluteal or deltoid muscle. 2.1 Prevention of Pregnancy Both the 1 mL vial and the 1 mL prefilled syringe of medroxyprogesterone acetate injectable suspension should be vigorously shaken just before use to ensure that the dose being administered represents a uniform suspension.
Directions from the U.S. FDA-approved label for Medroxyprogesterone Acetate — your doctor or pharmacist may advise differently.
The use of medroxyprogesterone acetate injectable suspension is contraindicated in the following conditions: Active thrombophlebitis, or current or history of thromboembolic disorders, or cerebral vascular disease. Known or suspected malignancy of breast. Known hypersensitivity to medroxyprogesterone acetate injectable suspension or any of its other ingredients. Significant liver disease. Undiagnosed vaginal bleeding. Active thrombophlebitis, or current or past history of thromboembolic disorders, or cerebral vascular disease.
Excerpt from the U.S. FDA-approved label for Medroxyprogesterone Acetate. Talk to a pharmacist or doctor before use.
Thromboembolic Disorders: Discontinue medroxyprogesterone acetate injectable suspension in patients who develop thrombosis. Cancer Risks: Monitor women with a strong family history of breast cancer carefully. Meningioma: Discontinue medroxyprogesterone acetate injectable suspension if meningioma is diagnosed. Monitor patients for signs and symptoms of meningioma. Ectopic Pregnancy: Consider ectopic pregnancy if a woman using medroxyprogesterone acetate injectable suspension becomes pregnant or complains of severe abdominal pain. Anaphylaxis and Anaphylactoid Reactions: Provide emergency medical treatment.
Warnings and precautions excerpt from the U.S. FDA-approved label for Medroxyprogesterone Acetate — not a complete list. Talk to a pharmacist or doctor before use.
The following important adverse reactions observed with the use of medroxyprogesterone acetate injectable suspension are discussed in greater detail in the Warnings and Precautions section: Loss of Bone Mineral Density Thromboembolic disease Breast Cancer Anaphylaxis and Anaphylactoid Reactions Bleeding Irregularities Weight Gain Most common adverse reactions (incidence >5%): menstrual irregularities (bleeding or spotting)…
Excerpt from the U.S. FDA-approved label for Medroxyprogesterone Acetate — not a complete list. Talk to a pharmacist or doctor about side effects.
7 brands · 4 makers in the NepalDoc catalog — see the full Medroxyprogesterone Acetate guide →
Stored upright at 20° to 25°C (68° to 77°F). Store at 20° to 25°C (68° to 77°F).
Storage information from the U.S. FDA-approved label for Medroxyprogesterone Acetate.
What is Deviry 10?
Deviry 10mg Tablet is a Medroxyprogesterone Acetate medicine made by Elder Pharmaceuticals. It comes as 10mg Tablet.
What is Deviry 10 used for?
Medroxyprogesterone Acetate is used for Menorrhagia, endometriosis, secondary amenorrhoea, contraception, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology.
What is the generic name of Deviry 10?
The generic name of Deviry 10 is Medroxyprogesterone Acetate.
Which brands of Medroxyprogesterone Acetate are available in Nepal?
7 brands of Medroxyprogesterone Acetate are listed in the NepalDoc catalog, from 4 makers — including Deviry 2.5mg Tablet, Orgamed 10mg Tablet, Provera 10mg Tablet, Provera 2.5mg Tablet, Provera 5mg Tablet, Sangini 150mg Injection.
What are the side effects of Medroxyprogesterone Acetate?
The following important adverse reactions observed with the use of medroxyprogesterone acetate injectable suspension are discussed in greater detail in the Warnings and Precautions section: Loss of Bone Mineral Density Thromboembolic disease Breast Cancer Anaphylaxis and Anaphylactoid Reactions Bleeding Irregularities Weight Gain Most common adverse reactions (incidence >5%): menstrual irregularities (bleeding or spotting)…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
